Mind Cure Health Inc. (MCURF) Stock

About Mind Cure Health Inc.

Mind Cure Health Inc., founded in Vancouver, Canada, in 2020, is a life sciences firm dedicated to improving mental health and wellness. The company develops and commercializes innovative products across North America, concentrating its efforts on pioneering digital therapeutics technology and exploring psychedelic compounds. This strategic approach aims to significantly broaden the availability of scientifically validated and evidence-based mental health treatments. Key offerings include iSTRYM, a distinctive digital therapeutics software designed to optimize the healing process for both patients and clinicians at all stages of therapy. Mind Cure also provides PsyCollage, a bioinformatics platform that helps prioritize research endeavors, and produces synthetic ibogaine to support researchers and medical professionals. Additionally, the company is investigating various psychedelic compounds, suchibogaine, for potential applications in treating traumatic brain injuries and related disorders.

Mind Cure Health Inc. is headquartered in CA.

Mind Cure Health Inc. (MCURF) stock trades at $0.51 with a market capitalization of $86.53M. The stock is valued at a price-to-earnings (P/E) ratio of -4.76, price-to-book of 9.43, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $0.51, and currently trades at its 52-week high.

On profitability, Mind Cure Health Inc. generates a return on equity (ROE) of -102.08%, return on capital employed of -82.99%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.mindcure.com